A pivotal life sciences investment for London’s Canary Wharf

Canary Wharf Group and AXA IM Alts' Kadans Science Partner will be investing £500m in Europe's largest commercial lab building.

PRIVATE REAL ESTATE

Register to unlock this content

• Daily global private real estate news and market intelligence
• Expertly curated insights to keep you ahead of the market
• Faster, data-driven decision-making powered by our AI interface, Ask PEI
• Access to proprietary research and reports
• Selected investor strategy and competitor performance data

Register nowFind out more

ManagersEurope